Pandemic Darlings The pandemic economy, in original documents
Home Source documents H.R. 6832, Ensuring Fairness for State Contracts Relating to Supplies to Combat COVID–19 Pandemic

H.R. 6832, Ensuring Fairness for State Contracts Relating to Supplies to Combat COVID–19 Pandemic

Summary

H.R. 6832, a bill introduced in the House of Representatives on February 25, 2022 by Mr. Cloud and other members, referred to the Committee on Energy and Commerce and, in addition, the Committee on Financial Services. The bill amends the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies. It would also bar the President from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID–19 pandemic.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Issuer
Congressional materials
Document type
Bills Bills 117Hr6832Ih Bills 117Hr6832Ih
Case
Bills Bills 117Hr6832Ih Bills 117Hr6832Ih

Cite this document

“H.R. 6832, Ensuring Fairness for State Contracts Relating to Supplies to Combat COVID–19 Pandemic.” Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-117hr6832ih-bills-117hr6832ih/, SHA-256 7351cc19bd3685b78a0eda96b2b4bd71f5ec1386b522f02545261a84c5d95299.

Full text

                                                                                                                                                                        I




                                                                     117TH CONGRESS
                                                                        2D SESSION
                                                                                                           H. R. 6832
                                                                     To amend the Federal Food, Drug, and Cosmetic Act and the Defense
                                                                         Production Act of 1950 to prohibit the Federal Government from limiting
                                                                         State access to key therapies, such as monoclonal antibodies, and from
                                                                         prioritizing Federal contracts over State contracts relating to purchasing
                                                                         supplies to combat the COVID–19 pandemic.




                                                                                   IN THE HOUSE OF REPRESENTATIVES
                                                                                                   FEBRUARY 25, 2022
                                                                     Mr. CLOUD (for himself, Mr. WEBSTER of Florida, Mr. BIGGS, Mrs. MILLER
                                                                         of Illinois, Mr. TIFFANY, and Mr. DONALDS) introduced the following bill;
                                                                         which was referred to the Committee on Energy and Commerce, and in
                                                                         addition to the Committee on Financial Services, for a period to be subse-
                                                                         quently determined by the Speaker, in each case for consideration of such
                                                                         provisions as fall within the jurisdiction of the committee concerned




                                                                                                               A BILL
                                                                     To amend the Federal Food, Drug, and Cosmetic Act and
                                                                        the Defense Production Act of 1950 to prohibit the Fed-
                                                                        eral Government from limiting State access to key thera-
                                                                        pies, such as monoclonal antibodies, and from prioritizing
                                                                        Federal contracts over State contracts relating to pur-
                                                                        chasing supplies to combat the COVID–19 pandemic.

                                                                       1               Be it enacted by the Senate and House of Representa-
                                                                       2 tives of the United States of America in Congress assembled,




pbinns on DSKJLVW7X2PROD with BILLS


                                      VerDate Sep 11 2014   05:45 Apr 07, 2022   Jkt 029200   PO 00000   Frm 00001   Fmt 6652   Sfmt 6201   E:\BILLS\H6832.IH   H6832
                                                                                                                                2
                                                                       1     SECTION 1. ENSURING FAIRNESS FOR STATE CONTRACTS

                                                                       2                             RELATING TO SUPPLIES TO COMBAT COVID–

                                                                       3                             19 PANDEMIC.

                                                                       4               (a) TREATMENT UNDER DEFENSE PRODUCTION ACT
                                                                       5     OF 1950.—Section 101 of the Defense Production Act of

                                                                       6 1950 (50 U.S.C. 4511) is amended—
                                                                       7                        (1) in subsection (a), by striking ‘‘The Presi-
                                                                       8               dent’’ and inserting ‘‘Except as provided by sub-
                                                                       9               section (e), the President’’; and
                                                                     10                         (2) by adding at the end the following:
                                                                     11                ‘‘(e) EXCEPTION FOR STATE CONTRACTS RELATING
                                                                     12      TO COVID–19 PANDEMIC.—The President may not exer-

                                                                     13 cise the authority provided by subsection (a) on or after
                                                                     14 the date of the enactment of this subsection to prioritize
                                                                     15 the performance of contracts or orders of the Federal Gov-
                                                                     16 ernment relating to the purchase of supplies to combat
                                                                     17 the COVID–19 pandemic over the performance of con-
                                                                     18 tracts or orders of the government of a State or territory
                                                                     19 or possession of the United States relating to the purchase
                                                                     20 of such supplies.’’.
                                                                     21                (b) TREATMENT UNDER FEDERAL FOOD, DRUG,
                                                                     22      AND COSMETIC ACT.—Section 564(j) of the Federal Food,

                                                                     23 Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(j)) is
                                                                     24 amended by adding at the end the following:




pbinns on DSKJLVW7X2PROD with BILLS
                                                                     25                         ‘‘(5) Nothing in this section or any other provi-
                                                                     26                sion of law shall be construed to authorize the Sec-
                                                                                  •HR 6832 IH

                                      VerDate Sep 11 2014   05:45 Apr 07, 2022   Jkt 029200   PO 00000   Frm 00002   Fmt 6652   Sfmt 6201   E:\BILLS\H6832.IH   H6832
                                                                                                                                3
                                                                       1               retary to ration a drug authorized for use under this
                                                                       2               section, limit or restrict access to such a drug, or
                                                                       3               otherwise control the quantity of such a drug made
                                                                       4               available for or distributed to any State or territory,
                                                                       5               including by imposing any limitation on distribution
                                                                       6               of such a drug to governmental entities, such as re-
                                                                       7               quiring a State- and territorial-coordinated distribu-
                                                                       8               tion system or similar distribution system.’’.
                                                                       9               (c) USE OF COVID–19 RELIEF FUNDS TO PUR-
                                                                     10      CHASE SUPPLIES FOR STATES.—

                                                                     11                         (1) IN GENERAL.—Notwithstanding any other
                                                                     12                provision of law, a State or territory or possession
                                                                     13                of the United States may use funds described in
                                                                     14                paragraph (2) to purchase supplies to combat the
                                                                     15                COVID–19 pandemic that the State, territory, or
                                                                     16                possession was unable to purchase before the date of
                                                                     17                the enactment of this Act because of the invocation
                                                                     18                by the President of the authority to prioritize con-
                                                                     19                tracts and orders under section 101 of the Defense
                                                                     20                Production Act of 1950 (50 U.S.C. 4511).
                                                                     21                         (2) FUNDS DESCRIBED.—Funds described in
                                                                     22                this paragraph are funds made available to a State
                                                                     23                or territory or possession of the United States pur-
                                                                     24                suant to any of the following Acts and available for



pbinns on DSKJLVW7X2PROD with BILLS                                               •HR 6832 IH

                                      VerDate Sep 11 2014   05:45 Apr 07, 2022   Jkt 029200   PO 00000   Frm 00003   Fmt 6652   Sfmt 6201   E:\BILLS\H6832.IH   H6832
                                                                                                                                4
                                                                       1               obligation as of the date of the enactment of this
                                                                       2               Act:
                                                                       3                                 (A) The Coronavirus Preparedness and
                                                                       4                        Response Supplemental Appropriations Act,
                                                                       5                        2020 (Public Law 116–123; 134 Stat. 146).
                                                                       6                                 (B) The Families First Coronavirus Re-
                                                                       7                        sponse Act (Public Law 116–127; 134 Stat.
                                                                       8                        178).
                                                                       9                                 (C) The Coronavirus Aid, Relief, and Eco-
                                                                     10                         nomic Security Act (Public Law 116–136; 134
                                                                     11                         Stat. 281).
                                                                     12                                  (D) The Paycheck Protection Program and
                                                                     13                         Health Care Enhancement Act (Public Law
                                                                     14                         116–139; 134 Stat. 620).
                                                                     15                                  (E) The Consolidated Appropriations Act,
                                                                     16                         2021 (Public Law 116–260).
                                                                     17                                  (F) The American Rescue Plan Act of
                                                                     18                         2021 (Public Law 117–2).
                                                                     19                                  (G) Any other Act providing funding relat-
                                                                     20                         ing to the COVID–19 pandemic.
                                                                                                                                Æ




pbinns on DSKJLVW7X2PROD with BILLS                                               •HR 6832 IH

                                      VerDate Sep 11 2014   05:45 Apr 07, 2022   Jkt 029200   PO 00000   Frm 00004   Fmt 6652   Sfmt 6301   E:\BILLS\H6832.IH   H6832


File and source

File
BILLS_bills-117hr6832ih_bills-117hr6832ih.pdf
Size
234,745 bytes
SHA-256
7351cc19bd3685b78a0eda96b2b4bd71f5ec1386b522f02545261a84c5d95299
Our copy
BILLS_bills-117hr6832ih_bills-117hr6832ih.pdf
Original
www.govinfo.gov
Back to top